Berry Genomics Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	309.75	383.07	338.15	333.56	417.89	629.31
Trading Asset Securities	10.48	17.03	13.86	4.51	3.82	3.82
Cash & Short-Term Investments	320.23	400.1	352.01	338.07	421.7	633.12
Cash Growth	32.36%	13.66%	4.12%	-19.83%	-33.39%	35.19%
Accounts Receivable	647.55	694.72	815.21	1,063	1,109	1,071
Other Receivables	66.58	76.45	4.97	14.51	34.07	45.71
Receivables	714.13	771.17	820.18	1,077	1,143	1,117
Inventory	183.66	194.91	229.3	230.95	233.88	180.27
Prepaid Expenses	-	0.01	0.14	0.21	1.88	2.92
Other Current Assets	80.04	72.9	71.37	80.15	105.88	74.65
Total Current Assets	1,298	1,439	1,473	1,727	1,907	2,008
Property, Plant & Equipment	540.96	459.07	923.42	1,101	1,131	909.28
Long-Term Investments	188.31	177.19	48.45	138.26	279.07	167.14
Goodwill	13.43	13.43	13.43	13.43	13.43	13.43
Other Intangible Assets	29.17	31.68	49.67	51.6	52.21	53.9
Long-Term Deferred Tax Assets	145.67	144.07	151.27	104.8	63.93	26.36
Long-Term Deferred Charges	97.69	89.77	48.44	41.04	46.71	46.81
Other Long-Term Assets	30.11	30.42	33.49	26.66	27.05	19
Total Assets	2,344	2,385	2,741	3,203	3,520	3,244
Accounts Payable	217.22	287.51	292.48	278.9	339.93	243.29
Accrued Expenses	37.42	55.81	64.95	63.14	66.16	74.04
Short-Term Debt	152.45	113.42	202.64	203.69	190.54	123.11
Current Portion of Long-Term Debt	-	-	42.3	-	-	-
Current Portion of Leases	3.03	3.63	12.95	13	9.44	-
Current Income Taxes Payable	-4.19	3.9	11.91	0.38	13.44	18.15
Current Unearned Revenue	96.91	103.49	110.75	103.56	90.55	71.19
Other Current Liabilities	18.19	22.81	25.11	42.05	58.52	26.66
Total Current Liabilities	521.04	590.56	763.09	704.72	768.58	556.43
Long-Term Debt	-	-	42.18	126.6	185.7	236.34
Long-Term Leases	136.6	43.24	3.5	4.88	13.62	-
Long-Term Unearned Revenue	10.99	10.87	11.02	12.07	3.66	4.85
Long-Term Deferred Tax Liabilities	25.8	24.9	26.77	25.89	24.46	23.91
Total Liabilities	694.43	669.56	846.56	874.17	996.02	821.52
Common Stock	353.52	353.52	353.52	354.61	354.61	354.61
Additional Paid-In Capital	1,154	1,159	1,156	1,211	1,160	1,061
Retained Earnings	92.83	145.39	337.82	765.02	1,020	1,131
Treasury Stock	-	-	-	-44.52	-44.52	-160.42
Comprehensive Income & Other	18.78	21.1	16.5	15.39	0.63	2.73
Total Common Equity	1,620	1,679	1,864	2,301	2,490	2,388
Minority Interest	29.65	35.69	30.57	27.94	33.51	34.01
Shareholders' Equity	1,649	1,715	1,895	2,329	2,524	2,422
Total Liabilities & Equity	2,344	2,385	2,741	3,203	3,520	3,244
Total Debt	292.09	160.28	303.58	348.17	399.3	359.44
Net Cash (Debt)	28.14	239.82	48.43	-10.11	22.4	273.68
Net Cash Growth	-77.92%	395.21%	-	-	-91.81%	28.94%
Net Cash Per Share	0.08	0.68	0.14	-0.03	0.06	0.77
Filing Date Shares Outstanding	353.52	353.52	353.52	353.52	353.52	350.7
Total Common Shares Outstanding	353.52	353.52	353.52	353.52	353.52	350.7
Working Capital	777.02	848.53	709.9	1,022	1,138	1,452
Book Value Per Share	4.58	4.75	5.27	6.51	7.04	6.81
Tangible Book Value	1,577	1,634	1,801	2,236	2,425	2,321
Tangible Book Value Per Share	4.46	4.62	5.09	6.33	6.86	6.62
Buildings	-	317.47	606.22	684.23	684.08	691.39
Machinery	-	623.32	638.82	591.45	553.45	542.23
Construction In Progress	-	-	230.8	290.95	267.6	3.75

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.